Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05065970 |
|---|---|
| Brief Title: | Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy (IGNAZ) |
| First Submitted : | September 14, 2021 |
| First Submitted that Met QC Criteria : | September 23, 2021 |
| First Posted : | October 4, 2021 |
| Last Update Submitted that Met QC Criteria : | December 12, 2022 |
| Last Update Posted : | December 13, 2022 |